Free Trial
NASDAQ:PSNL

Personalis (PSNL) Stock Price, News & Analysis

Personalis logo
$5.64 +0.07 (+1.26%)
Closing price 04:00 PM Eastern
Extended Trading
$4.32 -1.32 (-23.32%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Personalis Stock (NASDAQ:PSNL)

Key Stats

Today's Range
$5.56
$5.85
50-Day Range
$4.59
$7.56
52-Week Range
$2.81
$7.79
Volume
1.00 million shs
Average Volume
1.02 million shs
Market Capitalization
$498.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.67
Consensus Rating
Buy

Company Overview

Personalis Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
77th Percentile Overall Score

PSNL MarketRank™: 

Personalis scored higher than 77% of companies evaluated by MarketBeat, and ranked 455th out of 1,836 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Personalis has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Personalis has only been the subject of 2 research reports in the past 90 days.

  • Read more about Personalis' stock forecast and price target.
  • Earnings Growth

    Earnings for Personalis are expected to grow in the coming year, from ($1.40) to ($0.99) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Personalis is -4.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Personalis is -4.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Personalis has a P/B Ratio of 1.97. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Personalis' valuation and earnings.
  • Percentage of Shares Shorted

    7.76% of the outstanding shares of Personalis have been sold short.
  • Short Interest Ratio / Days to Cover

    Personalis has a short interest ratio ("days to cover") of 6.2.
  • Change versus previous month

    Short interest in Personalis has recently increased by 11.56%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Personalis does not currently pay a dividend.

  • Dividend Growth

    Personalis does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.76% of the outstanding shares of Personalis have been sold short.
  • Short Interest Ratio / Days to Cover

    Personalis has a short interest ratio ("days to cover") of 6.2.
  • Change versus previous month

    Short interest in Personalis has recently increased by 11.56%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Personalis has a news sentiment score of 0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for Personalis this week, compared to 3 articles on an average week.
  • Search Interest

    Only 1 people have searched for PSNL on MarketBeat in the last 30 days. This is a decrease of -88% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Personalis insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $26,367.00 in company stock.

  • Percentage Held by Insiders

    Only 3.80% of the stock of Personalis is held by insiders.

  • Percentage Held by Institutions

    61.91% of the stock of Personalis is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Personalis' insider trading history.
Receive PSNL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Personalis and its competitors with MarketBeat's FREE daily newsletter.

PSNL Stock News Headlines

Personalis Q2 2025 Earnings Preview
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Magnificent Seven—seven stocks he believes could deliver similar gains in under six years. His full breakdown is now live.
Analyzing Personalis (NASDAQ:PSNL) and Assembly Biosciences (NASDAQ:ASMB)
Personalis, Inc. (PSNL) - Yahoo Finance
See More Headlines

PSNL Stock Analysis - Frequently Asked Questions

Personalis' stock was trading at $5.78 at the beginning of 2025. Since then, PSNL shares have decreased by 2.4% and is now trading at $5.64.

Personalis, Inc. (NASDAQ:PSNL) released its earnings results on Tuesday, August, 5th. The company reported ($0.23) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.25) by $0.02. Personalis had a negative net margin of 98.10% and a negative trailing twelve-month return on equity of 48.78%.
Read the conference call transcript
.

Personalis (PSNL) raised $100 million in an initial public offering on Thursday, June 20th 2019. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofA Merrill Lynch and Cowen and Company acted as the underwriters for the IPO and Oppenheimer was co-manager.

Personalis' top institutional shareholders include ARK Investment Management LLC (8.05%), AIGH Capital Management LLC (4.22%), Aberdeen Group plc (1.99%) and Sumitomo Mitsui Trust Group Inc. (0.73%). Insiders that own company stock include Christopher M Hall, Aaron Tachibana, Richard Chen, Stephen Michael Moore and Stephen Michael Moore.
View institutional ownership trends
.

Shares of PSNL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Personalis investors own include Digital Turbine (APPS), CrowdStrike (CRWD), Okta (OKTA), Unity Software (U) and Vuzix (VUZI).

Company Calendar

Today
8/05/2025
Last Earnings
8/05/2025
Next Earnings (Confirmed)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - GENERIC DRG
Sub-Industry
Healthcare
Current Symbol
NASDAQ:PSNL
CIK
1527753
Fax
N/A
Employees
400
Year Founded
N/A

Price Target and Rating

High Price Target
$9.00
Low Price Target
$6.00
Potential Upside/Downside
+35.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.29)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$81.28 million
Net Margins
-98.10%
Pretax Margin
-98.08%
Return on Equity
-48.78%
Return on Assets
-34.70%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.91
Quick Ratio
6.74

Sales & Book Value

Annual Sales
$84.61 million
Price / Sales
5.89
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.87 per share
Price / Book
1.97

Miscellaneous

Outstanding Shares
88,320,000
Free Float
84,969,000
Market Cap
$498.12 million
Optionable
Optionable
Beta
1.86

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:PSNL) was last updated on 8/5/2025 by MarketBeat.com Staff
From Our Partners